Abzena is a global life sciences services and technology group with headquarters in the UK and two US sites. Created through the incorporation of Antitope, PacificGMP, PolyTherics, The Chemistry Research Solution (TCRS) and Warwick Effect Polymers, Abzena offers a full range of solutions for the selection, development and manufacture of biopharmaceuticals as well as antibody- and protein-based products. Working with global organizations and academic groups, Abzena supports the development and manufacture of better treatments for patients and is committed to bringing next-generation therapies to patients worldwide. Eleven antibodies created using Abzena’s technologies are currently being progressed through clinical development.